Cafepharma Today

May 21 2025 - Medtronic plans to separate its diabetes business into a new company
Medtronic plans to separate its diabetes business into a new company
Moderna shares down after pulling Covid-flu combo vaccine application
Roche's Genentech sticks with Orionis in 2nd molecular glue deal worth $2B
RFK Jr. takes fire in Senate hearing on research cuts
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Five Prostate Cancer Diagnostics to Watch
Fierce Biomarkers
Wednesday, March 16, 2011 - 10:54am
tags:
prostate cancer, diagnostics, Myriad Genetics, Genomic Health, Oxford Gene Technology, Quanterix, Metamark Genetics
FDA To Novartis: Ciba Vision Needs An Eye Exam
Pharmalot
Wednesday, March 16, 2011 - 10:51am
tags:
FDA, Novartis, CIBA Vision
Zalicus: Expanding Drug Pipeline Helps Make It a Strong Buy
Seeking Alpha
Wednesday, March 16, 2011 - 10:47am
tags:
Zalicus
Roche acquires PVT to strengthen diagnostics unit
Pharma Times, UK
Wednesday, March 16, 2011 - 10:46am
tags:
Roche, diagnostics, M&A, PVT
Human Genome: Buy the Pipeline Before Glaxo Does
Seeking Alpha
Wednesday, March 16, 2011 - 10:43am
tags:
GSK, Human Genome Sciences, lupus, Benlysta
A Big Pain for Pfizer: Embeda Is Recalled
Seeking Alpha
Wednesday, March 16, 2011 - 10:43am
tags:
Pfizer, King, painkillers, Embeda
Novartis maps out a blockbuster future for INC424
Fierce Biotech
Wednesday, March 16, 2011 - 9:21am
tags:
Novartis, INC424, Incyte, JAK inhibitors, ruxolitinib, myelofibrosis
Jazz’s Xyrem Hits The Right Notes
Forbes
Wednesday, March 16, 2011 - 9:19am
tags:
Jazz Pharmaceuticals, Xyrem, narcolepsy
Kendle Risk-Reward Remains Favorable
Seeking Alpha
Wednesday, March 16, 2011 - 9:18am
tags:
Kendle
Extending the Competition in Parkinson's Disease
Motley Fool
Wednesday, March 16, 2011 - 9:17am
tags:
Parkinson's Disease, Impax, Merck, Novartis, Pfizer, GSK
Astellas, Partners Reach Settlement With Teva on Tarceva Patent
Bloomberg
Wednesday, March 16, 2011 - 9:17am
tags:
Astellas, Teva Pharmaceuticals, Tarceva, patents
Pfizer: Bigger Not Necessarily Better
Seeking Alpha
Wednesday, March 16, 2011 - 9:16am
tags:
Pfizer
Progenics posts larger 4Q loss as revenue falls
Yahoo/AP
Wednesday, March 16, 2011 - 9:15am
tags:
earnings, Progenics Pharmaceuticals
Making sense of the Alzheimer's drug pipeline
Fierce Biotech Research
Tuesday, March 15, 2011 - 12:31pm
tags:
Alzheimer's disease, Razadyne, Nivalin, Ortho-McNeil-Janssen, Exelon, Novartis, Aricept, Eisai, Pfizer, Namenda, Merz, Forest Labs, Eli Lilly, Elan, JNJ, Roche, MorphoSys
Millennium expands cancer pact with red-hot Seattle Genetics
Fierce Biotech
Tuesday, March 15, 2011 - 12:27pm
tags:
Millennium, Seattle Genetics, antibody-drug conjugate
Sequenom Passes This Key Test
Motley Fool
Tuesday, March 15, 2011 - 12:26pm
tags:
Sequenom
Tougher Sentencing For Pharma Fraud?
Pharmalot
Tuesday, March 15, 2011 - 11:20am
tags:
fraud
Study: Statins may reduce prostate cancer risk
Fierce Pharma
Tuesday, March 15, 2011 - 11:09am
tags:
prostate cancer, statins
Novartis Has Largest Japan Exposure Among Big Pharma
Barron's
Tuesday, March 15, 2011 - 11:08am
tags:
Novartis, Japan, Pfizer, Merck, Eli Lilly, GSK, Bristol-Myers Squibb, AstraZeneca, Sanofi
Incyte cancer drug meets goal in Europe study
Yahoo/AP
Tuesday, March 15, 2011 - 10:03am
tags:
Incyte, Europe, ruxolitinib, Novartis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.